Data on Electronic Sampling, Online Promotion, Tech-Enabled Reps, Customer Service, and iPads

Manhattan ResearchPharmaceutical and healthcare market research company Manhattan Research releases the tenth version of ePharma Physician®, its study focused on physicians connecting with pharmaceutical and biotech companies through the Internet, tech-enabled reps, and online promotion. ePharma Physicians comprise 88% of the U.S. physician population in 2010, up from 64% in 2006.

Manhattan Research broadened the topical focus of ePharma Physician® this year to analyze the growing number of touch points in the pharma-physician relationship. Electronic sampling, live video detailing, and physician use of mobile devices, including iPads, are a few of the topics with new and exciting data. Pharmaceutical and biotech companies, agencies, and medical content providers use the data to inform decision making when leveraging digital channels to interact with physicians. The study can be segmented to derive statistically relevant insights across more than 25 specialties.

Key topics:

  • Channel Mix: Online and offline sources used for pharma product information; display and search engine advertising; medical journals; specialty and professional medical websites; influence on prescribing behavior
  • Mobile: Interest in pharma activities on mobile devices; iPad ownership and purchase intent; professional activities conducted on the iPad
  • Rep Relationship and Tech Detailing: Rep use/attitudes, including reps using Tablet PC or iPad; desired rep services
  • Online Promotion: Types of e-detailing and non-personal promotion (NPP) used, number of times used, program duration; live video detailing; KOL-led speaker programs; HCP portals/microsites; online promotion attitudes, influence, and barriers; preferences for obtaining product information; ranking of e-detailing and video detailing programs by company (use and satisfaction)
  • Online Pharmaceutical Properties: Pharma product, corporate, service portal, and unbranded websites
  • Customer Service: Customer service portal use and features of interest; live online speaker events from pharma companies; preferences for communicating with reps and MSLs; interest in customer service through email, click-to-chat, click-to-call, video chat, and phone; reasons for registering for a service portal
  • Electronic Sampling: Use and frequency; preferences for obtaining samples

Complimentary White Paper
To access a complimentary white paper from ePharma Physician® v10.0, please visit http://www.manhattanresearch.com/research/white-papers/online-communication-physicians-pharma.aspx

About ePharma Physician®
ePharma Physician® v10.0 was conducted via online survey in Q2 2010 among 1,713 U.S. physicians who have looked online for pharmaceutical information, visited a pharmaceutical or biotech product or corporate website, or participated in an e-detailing program from a pharmaceutical or biotech company in the past 12 months.

For additional information, please visit http://www.manhattanresearch.com/epp

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a global pharmaceutical and healthcare market research and strategic advisory firm and conducts annual research studies covering eHealth trends among physicians and consumers. Broad consumer and physician research is complemented by analysis for over 100 consumer therapeutic segments and physician specialist segments. For more information, please visit http://www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.decisionresourcesinc.com.

Most Popular Now

Regorafenib to be tested in brain cancer patients …

Bayer announced that the regorafenib arm of the platform trial "GBM AGILE" (Glioblastoma Adaptive Global Innovative Learning Environment) opened for enrollment in the US ...

Sanofi and Google to develop new healthcare Innova…

Sanofi and Google will establish a new virtual Innovation Lab with the ambition to radically transform how future medicines and health services are delivered by tapping i...

Bristol-Myers Squibb provides update on pending me…

Bristol-Myers Squibb Company (NYSE: BMY) today provided an update on the approval process and timeline for the Company’s pending merger with Celgene Corporation (NASDAQ: ...

Japan becomes the first country to approve Roche's…

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Rozlytrek® (entrectinib) for the treatment of a...

Breztri Aerosphere (PT010) approved in Japan for p…

AstraZeneca announced that Breztri Aerosphere (budesonide/glycopyrronium/ formoterol fumarate), formerly PT010, has been approved in Japan as a triple-combination therapy...

FDA approves Amgen and Allergan's KANJINTITM (tras…

Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) announced that the U.S. Food and Drug Administration (FDA) has approved KANJINTITM (trastuzumab-anns) for all approved ind...

Vitamin D may not help your heart

While previous research has suggested a link between low levels of vitamin D in the blood and an increased risk of cardiovascular disease, a new Michigan State University...

Human-on-a-chip model tests cancer drug efficacy a…

A reconfigurable "body-on-a-chip" model could transform drug development by simultaneously measuring compound efficacy and toxicity, for both target cells and other organ...

Pathogen engineered to self-destruct underlies can…

A team of investigators has developed a cancer vaccine technology using live, attenuated pathogens as vectors. A feature of the vaccine causes these bacteria to self-dest...

Artificial DNA can control release of active ingre…

A drug with three active ingredients that are released in sequence at specific times: Thanks to the work of a team at the Technical University of Munich (TUM), what was o...

How gastric stem cells fight bacteria

Stem cells are not only key players in tissue regeneration, they are also capable of taking direct action against bacteria. This is the finding of a study conducted by re...

Researchers identify enzyme that suppresses immune…

Immunotherapies have transformed cancer care, but their successes have been limited for reasons that are both complex and perplexing. In breast cancer especially, only a ...